VRNA Verona Pharma plc ADRs

Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:VRP.

$6.16  -0.09 (-1.36%)
As of 05/07/2021 15:38:15 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  04/27/2017
Outstanding shares:  51,818,199
Average volume:  47,305
Market cap:   $323,345,562
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    925050106
ISIN:        US9250501064
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.36
PS ratio:   0.00
Return on equity:   -42.88%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy